Please login to the form below
From: Sales
Pfizer set to file Xeljanz for psoriasis
Set to add another indication after positive study results
Pfizer rumoured to be after AstraZeneca
Is this the return of the pharma mega-merger?
From: Sales
NICE backs two cancer drugs
Boehringer’s Giotrif and Janssen’s Velcade given final go-ahead for NHS use
Novartis pays $16bn for GSK's oncology portfolio
Swiss company strikes series of deals, including one to step away from vaccines
Sex is a good trick
But pharma companies - and payers - should stop incestuous ‘best practice’ behaviours and look for new ways of comparing options
Tuberculosis: treatment and prevention
One of the most significant global diseases, effective new TB therapies are sorely needed
Number of HCPs on Twitter tops 75,000
Doctors, nurses, pharmacists and consultants posting more than 152,000 tweets a day
Integrating multichannel marketing
External forces are driving the need for pharma to use a greater variety of channels to reach customers
Spectrum appoints Dr Dalna Harvey as regulatory project manager
She brings experience gained at firms such as Parexel, Chiron and Wyeth
Featured jobs
- Editorial Lead - Oxfordshire
- Negotiable
- Senior Account Manager- Med Comms, London
- Competitive Salary Offered
- Senior Account Executive- Med Coms, London
- Competitive Salary Offered
- Brand Manager GI Cancers
- On application
Subscribe to our email news alerts
Latest intelligence
- Study highlights value of internet for doctors in Eastern Europe
- Electronic direct mail is proving popular as online access increases...
- England’s clinical commissioning landscape
- Who are the real masters in the new NHS?...
- How will the new landscape of Hep C treatments affect patients?
- The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....
Quick links
